Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (691-700 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|August 19, 2010
Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trialsDiane E Milenic, Karen J Wong, Kwamena E Baidoo, et al.
Mabs|May 1, 2010
Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell linesEsther M Yoo, Li J Yu, Letitia A Wims, et al.
Mabs|April 29, 2010
The Antibody SocietyAndrew Bradbury
Mabs|September 25, 2010
Therapeutic antibodies directed at G protein-coupled receptorsCatherine J Hutchings, Markus Koglin, Fiona H Marshall
Mabs|November 6, 2010
Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumorsChong Wang, Xiaohui He, Bo Zhou, et al.
Mabs|April 4, 2013
Correlations between pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model with predictive capabilitiesSusan H Tam, Stephen G McCarthy, Kerry Brosnan, et al.
Mabs|April 9, 2013
A high-throughput media design approach for high performance mammalian fed-batch culturesYolande Rouiller, Arnaud Périlleux, Natacha Collet, et al.
Mabs|February 9, 2013
Rapid optimization and prototyping for therapeutic antibody-like moleculesLihui Xu, Neeraj Kohli, Rachel Rennard, et al.
Mabs|February 22, 2013
Thermodynamic and structural characterization of an antibody gelOsigwe Esue, Anna X Xie, Tim J Kamerzell, et al.
Mabs|July 30, 2014
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouseMarie Vincent, Géraldine Teppaz, Laurie Lajoie, et al.
Pageof 184

Showing results (691-700 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|August 19, 2010
Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trialsDiane E Milenic, Karen J Wong, Kwamena E Baidoo, et al.
Mabs|May 1, 2010
Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell linesEsther M Yoo, Li J Yu, Letitia A Wims, et al.
Mabs|April 29, 2010
The Antibody SocietyAndrew Bradbury
Mabs|September 25, 2010
Therapeutic antibodies directed at G protein-coupled receptorsCatherine J Hutchings, Markus Koglin, Fiona H Marshall
Mabs|November 6, 2010
Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumorsChong Wang, Xiaohui He, Bo Zhou, et al.
Mabs|April 4, 2013
Correlations between pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model with predictive capabilitiesSusan H Tam, Stephen G McCarthy, Kerry Brosnan, et al.
Mabs|April 9, 2013
A high-throughput media design approach for high performance mammalian fed-batch culturesYolande Rouiller, Arnaud Périlleux, Natacha Collet, et al.
Mabs|February 9, 2013
Rapid optimization and prototyping for therapeutic antibody-like moleculesLihui Xu, Neeraj Kohli, Rachel Rennard, et al.
Mabs|February 22, 2013
Thermodynamic and structural characterization of an antibody gelOsigwe Esue, Anna X Xie, Tim J Kamerzell, et al.
Mabs|July 30, 2014
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouseMarie Vincent, Géraldine Teppaz, Laurie Lajoie, et al.
Pageof 184